Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era-Reference-Cited by-同舟云学术

Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era

Published:2016-03-21 Issue:11 Volume:57 Page:2619-2625
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lehners Nicola,Krämer Isabelle,Schwarzbich Mark-Alexander,Ho Anthony D.,Witzens-Harig Mathias

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2016.1157869

Reference32 articles.

1. Occurrence and prognosis of extranodal lymphomas

2. Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era

3. Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

4. Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin

5. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDG-PET in HIV-Positive Patient with Extranodal Diffuse Large B-Cell Lymphoma;World Journal of Nuclear Medicine;2024-04-25

2. Clinical and prognostic effect of MYC protein score in patients with diffuse large B-cell lymphoma in relation to blood group secretor status;The Egyptian Journal of Haematology;2023

3. Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis;Aging and Cancer;2022-09

4. Clinicopathologic features and outcomes of diffuse large B-cell lymphoma with extranodal involvement: A retrospective analysis;Cancer Research, Statistics, and Treatment;2022

5. The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database;Translational Oncology;2021-07